ReportCORONAVIRUS
Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States
- View ORCID ProfileJustin D. Silverman1,2,*,†,
- View ORCID ProfileNathaniel Hupert3,4 and
- View ORCID ProfileAlex D. Washburne5,*,†
- 1College of Information Science and Technology, Penn State University, University Park, PA 16802, USA.
- 2Department of Medicine, Penn State University, Hershey, PA 17033, USA.
- 3Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.
- 4New York–Presbyterian Hospital, New York, NY 10065, USA.
- 5Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA.
- ↵†Corresponding author. Email: justinsilverman{at}psu.edu (J.D.S.); alex.d.washburne{at}gmail.com (A.D.W.)
↵* These authors contributed equally to this work.
See allHide authors and affiliations
Science Translational Medicine 29 Jul 2020:
Vol. 12, Issue 554, eabc1126
DOI: 10.1126/scitranslmed.abc1126
Vol. 12, Issue 554, eabc1126
DOI: 10.1126/scitranslmed.abc1126
Justin D. Silverman
1College of Information Science and Technology, Penn State University, University Park, PA 16802, USA.
2Department of Medicine, Penn State University, Hershey, PA 17033, USA.
Nathaniel Hupert
3Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.
4New York–Presbyterian Hospital, New York, NY 10065, USA.
Alex D. Washburne
5Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA.
